What do we mean by opioid sparing and what are its potential individual and societal benefits? Eric C. Strain, M.D. Johns Hopkins University School.

Slides:



Advertisements
Similar presentations
Discussant Inder Anand, MD, FRCP, D Phil (Oxon.)
Advertisements

Extension Article by Dr Tim Kenny
TM Centers for Disease Control and Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center.
Economic Analysis and Management Todd Wagner, PhD.
National Overdose Deaths Number of Deaths from Prescription Drugs.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Prescription Opioids: Extramedical Use and Overdose
Problem-solution Essay- Part 1
Prescription Drug Abuse. What is prescription drug abuse? Taking drugs for reasons or in ways or amounts not intended by the doctor The use of drugs by.
Endpoints for Stimulant Treatments: Persuading the Payor Eric C. Strain, M.D. Johns Hopkins University School of Medicine MOST Meeting March 25-26, 2015.
Slide 1 Best Practices Working Group Chapter 244 Acts of 2012 Joint Policy Working Group Bureau of Health Care Safety and Quality Director Madeleine Biondolillo,
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
KNOW THE FACTS: SERIES II Trends and Facts on Prescription Drug Abuse This document is confidential and is intended solely for the use and information.
A Revolution in Pain Pharmaceuticals 1. The Problem Opioids are the oldest and most prescribed pain drugs. They are the most powerful analgesics for treatment.
PRESCRIPTION DRUG ABUSE Part 2. LEARNING GOALS  I will be able to identify the pitfalls of prescription drug use.  I will be able to use the information.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
Medications for Spine Pain
Current Concepts in Pain Management
The Highs and Lows of Relapse and Recovery in Opioid Use Disorder
OPIOID EPIDEMIC.
How big is the problem? The Centers for Disease Control and Prevention (CDC) classifies prescription drug abuse as the fastest growing drug issue and epidemic.
What are Drugs?.
Jessica E. Bates, Pharm.D. PGY-1 Pharmacy Resident
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
New NC Medical Board Opioid Prescribing CME Requirements
THE OPIOID CRISIS Mississippi Board of Nursing
10th Annual Susan Li Conference
WHY A FOCUS ON ADDICTIVE BEHAVIORS?
Comparing abuse of extended-release versus immediate-release opioid analgesics adjusted for number of prescriptions and morphine-equivalent dose Stephen.
McLean Hospital Division of Alcohol and Drug Abuse
A presentation featuring
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Opioid Crisis A Call to ACTION
Risk evaluation and mitigation for use of opioids in chronic pain
Understanding the Opioid Crisis and what Kiwanis can do
Richard C. Dart, MD, PhD Executive Director, RADARS System
ROOM project Addressing the Opioid Epidemic in the U.P.
Know the facts: Series II
Opioid Prescribing & Monitoring
The Myths and Realities of the Opioid Epidemic AMERSA November 3, 2017
What are Drugs?.
What Works? Evidence-Based Practices for Treating Opioid Use Disorder
Mitigating the Safety Risks of Drugs With a Focus on Opioids: Are Risk Evaluation and Mitigation Strategies the Answer?  Marta J. Brooks, PharmD  Mayo.
Barbara Allison-Bryan, MD
Flash Talk Can Medical Marijuana Be a Solution to the Opioid Crisis?
The Opioid Epidemic: Crisis in the Workplace
Pain Management: Patients Maintained on Buprenorphine
Opioids in Butte County
Assessing Opioid Use Disorder, part 1
Pain Management and Substance Use Disorders: JCPP Strategic Session
Jim Langford – Georgia Prevention Project November 5, 2018
The Opioid Crisis and You.
Opioid Use Disorders: Recognition and Pharmacotherapy Review
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Academic Detailing (AD): A New Resource From AR-IMPACT
National Overdose Deaths Number of Deaths Involving All Drugs
Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, Figure 1. National Drug Overdose Deaths—Number Among All Ages, by Gender,
The Emerging Threat of Stimulants
Drugs Involved in U. S. Overdose Deaths
National Overdose Deaths Number of Deaths from All Drugs
Dr. Mark Levine, Commissioner of Health
The Transition from Prescription Opioid Drug Abuse to Heroin Use
IMMPACT-XXI July 26-27, 2018 Washington, DC
Substance Use Prevention for Young Adults and Higher Education
Developing Indicators of Success
National Overdose Deaths Number of Deaths from All Drugs
Tramadol/Paracetamol Fixed-dose Combination in the Treatment of Moderate to Severe Pain Joseph V Pergolizzi Jr, Mart van de Laar, Richard Langford, Hans-Ulrich.
Tapering and Discontinuing Chronic Opioid Therapy
Presentation transcript:

What do we mean by opioid sparing and what are its potential individual and societal benefits? Eric C. Strain, M.D. Johns Hopkins University School of Medicine IMMPACT XXI , Washington, MD July 26, 2018

Disclosures In the past year, I have served on advisory boards, received grant funding from, and/or consulted for: Alkermes, Analgesic Solutions, Caron, Indivior Pharmaceuticals, The Oak Group, OrphoMed, Pinney Associates, and the WHO. 1.

I am a fish out of water on much of this topic 1.

Outline for this talk I. What do we mean by “opioid sparing”? II. Why do we care about opioid sparing? III. Does opioid sparing matter? IV. Final thoughts 1.

Outline for this talk I. What do we mean by “opioid sparing”? II. Why do we care about opioid sparing? III. Does opioid sparing matter? IV. Final thoughts 1.

Opioid sparing Strategies that accomplish one of the following: 1. Decrease in the acute dose of opioid that is taken 2. Decrease in the total number of doses of opioid taken 3. Decrease in some aspect of the opioid effect (e.g., side effect) 4. Not require the use of an opioid 1.

Opioid sparing Strategies that accomplish one of the following: 1. Decrease in the acute dose of opioid that is taken 2. Decrease in the total number of doses of opioid taken 3. Decrease in some aspect of the opioid effect (e.g., side effect) 4. Not require the use of an opioid Underlying this is the assumption that there is at least no change in outcome with respect to the target clinical measure (analgesia) 1.

Outline for this talk I. What do we mean by “opioid sparing”? II. Why do we care about opioid sparing? III. Does opioid sparing matter? IV. Final thoughts 1.

Why do we care about opioid sparing? We have an opioid (abuse, misuse, addiction, dependence, use disorder) problem 1.

1.

Why do we care about opioid sparing? We have an opioid (abuse, misuse, addiction, dependence, use disorder) problem Underlying assumption is that decreasing exposure to prescription opioids will decrease risk of developing problematic opioid use Looking for both an individual and societal benefit 1.

Why do we care about opioid sparing? How bad is the problem of opioid abuse in the U.S.? 1.

Opioid prescriptions dispensed

Opioid prescriptions dispensed

Opioid prescriptions dispensed

Opioid prescriptions dispensed

Opioid prescriptions dispensed

Opioid prescriptions dispensed Steady increase

Opioid prescriptions dispensed Starting to see some decrease?

Opioid abuse Another problem with respect to opioid use is overdose deaths from use of opioids

Opioid overdoses 1.

Opioid overdoses 1.

Opioid overdoses 1.

Opioid overdoses 1.

Opioid overdoses Slow steady rise in rx opioids (2000) 1.

Opioid overdoses Sudden rise in heroin (2010) 1.

Opioid overdoses Dramatic increase in fentanyl (2014) 1.

Opioid overdoses – what I showed 2 years ago… 1.

We have seen a change in the US death rate 1.

We have seen a change in the US death rate 1.

We have seen a change in the US death rate 1.

We have seen a change in the US death rate Different countries shown 1.

We have seen a change in the US death rate US White non-Hispanic 1.

We have seen a change in the US death rate 1.

We have seen a change in the US death rate US Hispanic 1.

We have seen a change in the US death rate 1.

We have seen a change in the US death rate 1.

We have seen a change in the US death rate 1.

We have seen a change in the US death rate A greater relative increase 1.

Epidemiology of opioid abuse We are very focused on opioid use and opioid overdoses, but we don’t have an opioid problem, we have a substance use problem – we are playing whack a mole so long as we focus on one drug type or drug class…

Taking our eyes off the cocaine ball… Cocaine has doubled (and note MA) 1.

Epidemiology of opioid abuse Where do people get opioids, and especially prescription opioids?

Epidemiology of opioid abuse Where do people get opioids, and especially prescription opioids? Varies as a function of whether have problematic use of prescription opioids…

Source of prescription opioids From Han et al., Ann Int Med, 2017 Used NSDUH data from 2015

Source of prescription opioids

Source of prescription opioids

Source of prescription opioids No Use Disorder, getting for free from family (two- fold difference)

Source of prescription opioids Use Disorder, buying from friend/ relative

Source of prescription opioids Use Disorder, buying from others (a lot more)

Why do we care about opioid sparing? To summarize why we care about opioid sparing (I of II): Increased exposure to opioids has resulted in more problematic use (although why people use opioids is complicated, and just getting opioids is not the reason people misuse them) This exposure has been related, in part, to increased prescribing Increased opioid overdose deaths 1.

Why do we care about opioid sparing? To summarize why we care about opioid sparing (II of II): Some proportion of people exposed to an opioid go on to develop problematic use of it (although we really don’t know what that is) Even for those who don’t directly develop a problem after exposure, the availability of opioids may result in diversion to others who then develop misuse of opioids 1.

Outline for this talk I. What do we mean by “opioid sparing”? II. Why do we care about opioid sparing? III. Does opioid sparing matter? IV. Final thoughts 1.

Does opioid sparing matter? If sparing means no exposure to an opioid, then likely that sparing matters – we decrease the denominator under the circumstances of what is probably some relatively stable ratio of people who run the risk of developing an opioid use disorder (so we eventually decrease the number with problem use) On the other hand, if we decrease the amount of exposure (but not the experience of being exposed to an opioid), then this probably gets more complicated… 1.

Does opioid sparing matter? Things to consider if we decrease the amount of exposure: 1. Exposure to an opioid induces some immediate changes (e.g., acute physical dependence, shown in humans) - So, maybe doesn’t really matter for the individual - Clinical experience of first dose by people who go on to develop opioid use disorder (like it from the start) 1.

Does opioid sparing matter? Things to consider if we decrease the amount of exposure: 2. Certainly more typical physical dependence with repeated (chronic) exposure, depending upon the 3Ds – drug, dose, days - Decreased risk of physical dependence if decrease total amount of exposure (but physical dependence is not problematic use…) 1.

Does opioid sparing matter? Things to consider if we decrease the amount of exposure: 3. More doses “out there” runs risk of more potential for diversion, misuse - Note that decreasing availability of prescription opioids appears to be shifting use to heroin and fentanyl - May have a long-term value to decrease available doses of rx opioids, but shorter term may actually be increasing individual and societal cost (deaths) 1.

Does opioid sparing matter? Opioid sparing could also have other repercussions: 1. Alternative could be more expensive to health care system 2. Use of another substance could have more downstream problems (individual, societal – e.g., is cannabis really the solution?) 3. Individual efficacy may be lower 1.

Does opioid sparing matter? The bottom line: Opioid sparing can have value for individual prescribed, and for society 1.

Does opioid sparing matter? The bottom line: Opioid sparing can have value for individual prescribed, and for society However, important to note that as we decrease prescription opioid use/exposure, we are seeing a backfilling with illicit opioid use (e.g., fentanyl) – sparing by itself won’t solve the opioid problem, and may be actually producing more societal pain and individual suffering 1.

Outline for this talk I. What do we mean by “opioid sparing”? II. Why do we care about opioid sparing? III. Does opioid sparing matter? IV. Final thoughts 1.

Final thoughts The value of opioid sparing likely depends upon the approach used to spare the opioid The drive to “spare” opioid use is good and reasonable, and likely could decrease further development of opioid use problems (but we may have passed the prescription opioid use phase of the crisis) The problem did not develop overnight, and the solution will not be equally quick as a fix (despite desires to do so and good intentions) 1.

Thank you 1.

Opioid sparing What do we mean by “opioid sparing”? 1.

Opioid sparing What do we mean by “opioid sparing”? So I will figure this out by googling the term (because what else do we do these days?) 1.

1.

1.

1.

What are the forces that are pushing the concept of ”opioid sparing”? 1.